Evidence map›Paper›PMID 20109979›Full record

ReviewCurrent problems in cardiology2010

Growing epidemic of coronary heart disease in low- and middle-income countries.

Thomas A Gaziano, Asaf Bitton, Shuchi Anand, Shafika Abrahams-Gessel, Adrianna Murphy

Abstract readReview
In one paragraph

Review in Current problems in cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 469 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
469citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

469 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Article
  19. Article
  20. Article

409 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas A Gaziano
Asaf Bitton
Shuchi Anand
Shafika Abrahams-Gessel
Adrianna Murphy

Funding

TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007357 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 1986 to 2022
$4.8M
Cost-effective prevention of cardiovascular disease in developing countriesK01TW007141 · FIC · BRIGHAM AND WOMEN'S HOSPITAL · PI GAZIANO, THOMAS A · 2004 to 2011
$864k
FIC NIH HHS 2K01TW007141-05FIC NIH HHS K01 TW007141NIDDK NIH HHS T32 DK007357
6 · The paper itself

Abstract

Coronary heart disease (CHD) is the single largest cause of death in the developed countries and is one of the leading causes of disease burden in developing countries. In 2001, there were 7.3 million deaths due to CHD worldwide. Three-fourths of global deaths due to CHD occurred in the low- and middle-income countries. The rapid rise in CHD burden in most of the low- and middle-income countries is due to socio-economic changes, increase in lifespan, and acquisition of lifestyle-related risk factors. The CHD death rate, however, varies dramatically across the developing countries. The varying incidence, prevalence, and mortality rates reflect the different levels of risk factors, other competing causes of death, availability of resources to combat cardiovascular disease, and the stage of epidemiologic transition that each country or region finds itself. The economic burden of CHD is equally large but solutions exist to manage this growing burden.

Indexed as

Disease OutbreaksGlobal HealthCoronary DiseaseCost-Benefit AnalysisCost of IllnessDeveloping CountriesHealth Care CostsHealth Services AccessibilityHumansIncidenceLife StyleLongevityPrevalenceQuality-Adjusted Life YearsResidence CharacteristicsRisk Factors

Identifiers

PMID20109979
PMCPMC2864143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.